Floris Grasmeijer (F Grasmeijer)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Topics

Pulmonary Hypertension

Stem Cell Transplantation

Top Venues

Expert opinion on drug delivery

Therapeutic advances in chronic disease

This page only lists publications with an associated author ORCID identifier.

Publications

Anne Haaije de Boer, Paul Hagedoorn, Floris Grasmeijer
Dry powder inhalation, part 2: the present and future. Expert opinion on drug delivery 19 (9) (2022)
Anne Haaije de Boer, Paul Hagedoorn, Floris Grasmeijer
Dry powder inhalation, part 1: ancient history and precursors to modern dry powder inhalers. Expert opinion on drug delivery 19 (9) (2022)
Y A de Reus, P Hagedoorn, M G G Sturkenboom, Floris Grasmeijer, M S Bolhuis, I Sibum, H A M Kerstjens, H W Frijlink, Onno W Akkerman
Tolerability and pharmacokinetic evaluation of inhaled dry powder hydroxychloroquine in healthy volunteers. PloS one 17 (8) (2022)
Marianne Luinstra, Wijnand Rutgers, Teus van Laar, Floris Grasmeijer, Anja Begeman, Valmira Isufi, Luc Steenhuis, Paul Hagedoorn, Anne de Boer, Henderik W Frijlink
Pharmacokinetics and tolerability of inhaled levodopa from a new dry-powder inhaler in patients with Parkinson's disease. Therapeutic advances in chronic disease 10 (2019)
Imco Sibum, Paul Hagedoorn, Henderik W Frijlink, Floris Grasmeijer
Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation. Pharmaceutics 11 (5) (2019)
Imco Sibum, Paul Hagedoorn, Markus P G Kluitman, Martijn Kloezen, Henderik W Frijlink, Floris Grasmeijer
Dispersibility and Storage Stability Optimization of High Dose Isoniazid Dry Powder Inhalation Formulations with L-Leucine or Trileucine. Pharmaceutics 12 (1) (2019)